| |
 |
Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]
 |
| |
|
pp.1039-1039 (1) Authors: N. Sharifi, J. B. Aragon-Ching |
| |
|
|
| |
|
Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer
|
| |
|
pp.1040-1045 (6) Authors: Patrick Lee, Jeanny B. Aragon-Ching |
| |
|
|
| |
|
Hormonal Therapy for Prostate Cancer: Toward Further Unraveling of Androgen Receptor Function
|
| |
|
pp.1046-1051 (6) Author: Nima Sharifi |
| |
|
|
| |
|
Current Perspectives in Prostate Cancer Vaccines
|
| |
|
pp.1052-1057 (6) Authors: Philip M. Arlen, James L. Gulley |
| |
|
|
| |
|
Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
|
| |
|
pp.1058-1069 (12) Authors: Tristan M. Sissung, Silja Thordardottir, Erin R. Gardner, William D. Figg |
| |
|
|
| |
|
Angiogenesis Inhibition in the Treatment of Prostate Cancer
|
| |
|
pp.1070-1078 (9) Authors: Ravi A. Madan, William L. Dahut |
| |
|
|
| |
|
Agents Targeting Prostate Cancer Bone Metastasis
|
| |
|
pp.1079-1088 (10) Authors: Khalid S. Mohammad, Pierrick G. Fournier, Theresa A. Guise, John M. Chirgwin |
| |
|
|
| |
|
Kinase Inhibitors in Prostate Cancer
|
| |
|
pp.1089-1104 (16) Authors: Suwicha Limvorasak, Edwin M. Posadas |
| |
|
|
| |
|
Targeting Prostate Cancer Stem Cells
|
| |
|
pp.1105-1113 (9) Authors: Francesco Crea, Lesley A. Mathews, William L. Farrar, Elaine M. Hurt |
| |
|
|
| |
|
An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
|
| |
|
pp.1114-1122 (9) Authors: Katsuyoshi Miyashita, Mitsutoshi Nakada, Abbas Shakoori, Yasuhito Ishigaki, Takeo Shimasaki, Yoshiharu Motoo, Kazuyuki Kawakami, Toshinari Minamoto |
| |
|
|
| |
|
Local Treatment for Lymphoid Malignancies of the Eye
|
| |
|
pp.1123-1128 (6) Authors: Gian Paolo Giuliari, David M. Hinkle, C. Stephen Foster |
| |
|
|
